Walgreens Boots Alliance, Inc. (NASDAQ: WBA ) was one of the biggest investment mistakes I made in the last few years. I sold part of my position already a few quarters ago and avoided further losses, but theMy analysis is focused on high-quality companies, that can outperform the market over the long-run due to a competitive advantage (economic moat) and high levels of defensibility. Focused on European and North American companies, but without constraints regarding market capitalization (from large cap to ...

Walgreens Boots Alliance (WBA) will release its first-quarter fiscal 2024 results (ended Nov. 30) on Jan. 10 before the market opens.  Stay up-to-date with all quarterly releases: See Zacks Earnings Calendar.The Zacks Consensus Estimate for the company’s fiscal first-quarter earnings has moved down 5.1% to 30 cents in the past 30 days. The estimate indicates a 43.6% plunge from the year-ago comparable figure. However, revenues are expected to improve slightly by 1.1% to $37.1 billion.Image Source: Zacks Inv ...

Earnings and Revenue Expectations - Wall Street analysts expect Walgreens Boots Alliance (WBA) to post quarterly earnings of $0.37 per share, indicating a year-over-year decline of 43.9% [1] - Revenues are expected to be $37.1 billion, up 1.1% from the year-ago quarter [1] - The consensus EPS estimate for the quarter has been adjusted upward by 0.7% over the past 30 days, reflecting analysts' reassessment of initial projections [1] Importance of Earnings Revisions - Revisions to earnings projections are critical for predicting potential investor behaviors and short-term stock price performance [2] - Empirical studies consistently reveal a strong link between trends in earnings estimate revisions and stock price performance [2] Key Metrics Analysis - Analysts forecast 'Revenues- U.S. Retail Pharmacy' to reach $29.19 billion, indicating a change of +0.9% from the prior-year quarter [4] - 'Revenues- International' is predicted to reach $5.91 billion, with a change of +1.4% from the prior-year quarter [4] - The consensus estimate for 'Revenues- U.S. Healthcare' stands at $2.04 billion, suggesting a change of +5.9% year over year [4] Detailed Revenue Breakdown - 'Revenues- U.S. Retail Pharmacy- Pharmacy' is expected to come in at $23.15 billion, indicating a change of +3.4% from the year-ago quarter [5] - 'Revenues- U.S. Retail Pharmacy- Retail' is forecasted to reach $6.31 billion, with a year-over-year change of -3.9% [5] Operating Income Projections - 'Adjusted operating income (loss)- U.S. Retail Pharmacy' is expected to reach $298.78 million, compared to the year-ago figure of $694 million [6] - 'Adjusted operating income (loss)- International' is projected to arrive at $165.99 million, compared to the year-ago value of $142 million [6]

It's been a tough year for Walgreens Boots Alliance (WBA -1.18%) stock, which is trading down nearly 65% year to date, as of this writing. Things don't look any better when looking even further out, as the stock has lost 88% of its value over the past decade.There have been rumors swirling of a possible buyout. Is now the time to buy this beaten-down stock?Can Walgreens turn around its business?The fall of Walgreens is due to a combination of self-inflected wounds and overall industry pressure. The company ...

Until recently, many Walgreens Boots Alliance (WBA -2.62%) investors were desperately hungry for good news to boost the company's languishing stock price. On Dec. 10 they got some, in the form of a news report detailing a potential buyout deal. That gave the shares a bit of a bump, but overall, investors remain cautious.Should they be so guarded, or is this an opportunity to snap up an underappreciated stock at a serious discount?Going private with a private equity player?That Dec. 11 report was published b ...

One of my most controversial articles of the year was no doubt a contrarian long idea on shares of Walgreens Boots Alliance, Inc. (NASDAQ: WBA ). In September, I called out a key technical development amid dreadful sentiment on theFreelance Financial Writer | Investments | Markets | Personal Finance | RetirementI create written content used in various formats including articles, blogs, emails, and social media for financial advisors and investment firms in a cost-efficient way. My passion is putting a narra ...

Walgreens Boots Alliance (WBA 0.95%) stock looks to have finally received some much-needed bullishness from investors. The stock was jumping last week on rumors that a private equity firm may be buying the company. While Walgreens stock is still down more than 60% this year (as of the end of last week), it is showing signs of life of late.But before you jump in and decide to take a chance on this beaten-down stock, there are some things to consider.An acquisition is not a surefire guarantee of a huge gainAc ...

BLOOMINGTON, Minn. and ATLANTA, Dec. 18, 2024 /PRNewswire/ -- CaringBridge, a nonprofit health platform, and Walgreens, an integrated healthcare, pharmacy and retail leader, are proud to announce a two-day campaign when Walgreens will match donations on CaringBridge up to $50,000 on December 17 and 18. The campaign complements a year-round initiative on CaringBridge.TheGiftCardShop.com, an e-commerce website where consumers can purchase and send gift cards directly to caregivers. Since launching gift card o ...

The company could soon start growing earnings again, offering investors an 11% dividend yield.Walgreens Boots Alliance (WBA 6.78%) is a household name in the healthcare industry. Consumers in America and worldwide have frequented their neighborhood pharmacies for generations.However, the company has fallen on hard times. Clumsy efforts to expand the business scuttled the balance sheet and triggered a 90% decline from the stock's high.The turnaround efforts have started. Management is slashing debt from the ...

With its shares falling more than 80% over the last three years alone, investors are likely eager for a major shakeup in the way that Walgreens Boots Alliance (WBA 6.78%) does business. If the rumors are to be believed, that shakeup could be coming very soon, and it would affect every shareholder.But does that make the stock worth buying? Let's look at what's possible here and figure it out.Why this potential big change could be for the betterBefore addressing the rumor in question, it's worth taking a minu ...